Body Handbook Catalogue Profile Ranking
Gut BODY HANDBOOK
Gut ยท ยง72
IBD Red Flags
Most cramping, bloating, and altered stool is irritable bowel syndrome, and the label is usually right. But a quiet minority have inflammatory bowel disease, Crohn's or ulcerative colitis, hiding inside the same symptoms while the bowel wall takes damage. A few red flags tell them apart: blood in the stool, pain that wakes you at night, unplanned weight loss, anaemia, a joint or eye that flares with the gut. Any one means it isn't plain IBS, and catching it early lets treatment hold.
Condition Evidence Strong Chapter Gut

IBS is a wiring problem; IBD is a damage problem. In IBS the gut and brain misfire, so there's pain and urgency, but the bowel wall looks normal through a camera 1. In IBD the immune system attacks the lining: ulcers form, scars build, the wall narrows. Both feel the same at first; only one leaves marks.

The red flags are the symptoms only the damage produces. Dark blood mixed into stool, or blood with mucus, is the lining itself bleeding rather than a haemorrhoid. A swollen joint, a red light-sensitive eye, or tender lumps on the shins turn up in a quarter to a third of IBD patients, sometimes before the gut gets loud 2.

The wrong label costs years of treatment window. Crohn's takes a median nine months to diagnose, the slower quarter over two years โ€” and the longer the wait, the more narrowing, fistulas, and surgery by the time it's caught 3 4. The drugs hold Crohn's while it's inflammation-only and work far less well once it scars 5.

One cheap stool test does most of the sorting. Fecal calprotectin leaks from inflamed gut wall in proportion to the inflammation, flagging IBD with about 93% sensitivity and clearing non-IBD causes with 96% specificity โ€” sharper than any blood marker 6. A normal CRP alone doesn't clear you: it misses one active Crohn's case in five 7.

Chronic gut symptoms plus any red flag means the next visit is for objective testing, not more diet advice. Ask for the workup by name.

If it comes back clean, the IBS diagnosis is a positive answer rather than a default, and that unlocks real IBS treatment.

If the workup confirms IBD, relief tracks the drug. Weeks one to four: urgency settles, night trips stop, blood fades. Months three to six: iron refills, colour returns, and mucosal healing on a repeat scope buys longer remission and less surgery 5. The trade-off is long-term medication and monitoring. Caught early, the disease had less to hold.

The fine print โ€” when to skip it, and what people get wrong
  • "It's IBS getting worse." IBS is a stable pattern by definition; progressive worsening plus a red flag retires the label 1.
  • "Too young or too fit for IBD." New diagnoses peak at 15โ€“35, then again at 50โ€“70 9.
  • "It's just stress." Stress and IBD coexist; the stress framing is cover for not testing.
  • An IBS label with no calprotectin skips the half of the work that earns it 1.
  • One normal calprotectin, never repeated. Patchy Crohn's spikes intermittently; retest in 4โ€“6 weeks if symptoms persist.
  • Diet-only management of suspected IBD soothes symptoms but doesn't heal the lining โ€” it's delay.
References
  1. 1Lacy BE, Mearin F, Chang L, et al. (2016). Bowel Disorders (Rome IV). Gastroenterology. link
  2. 2Vavricka SR, Schoepfer A, Scharl M, et al. (2015). Extraintestinal Manifestations of Inflammatory Bowel Disease. Inflammatory Bowel Diseases. link
  3. 3Schoepfer AM, Dehlavi MA, Fournier N, et al. (2013). Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate. American Journal of Gastroenterology. link
  4. 4Pellino G, Sciaudone G, Selvaggi F, Riegler G (2015). Delayed diagnosis is influenced by the clinical pattern of Crohn's disease and affects treatment outcomes. European Journal of Gastroenterology & Hepatology. link
  5. 5Colombel JF, Panaccione R, Bossuyt P, et al. (2017). Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial. The Lancet. link
  6. 6van Rheenen PF, Van de Vijver E, Fidler V (2010). Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ. link
  7. 7Vermeire S, Van Assche G, Rutgeerts P (2006). Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut. link
  8. 8Maaser C, Sturm A, Vavricka SR, et al. (2019). ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. Journal of Crohn's and Colitis. link
  9. 9Burisch J, Jess T, Martinato M, Lakatos PL (2013). The burden of inflammatory bowel disease in Europe. Journal of Crohn's and Colitis. link
ยท
72